Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.39 | 29.00 |
| PEG Ratio (TTM) | -0.02 | 1.71 |
| P/S Ratio (TTM) | 0.44 | 2.33 |
| P/B Ratio (TTM) | 0.22 | 2.87 |
| P/FCF Ratio (TTM) | N/A | 16.15 |
| Price to 5YR AVG Earnings Ratio | N/A | 9.52 |
| Price to 5YR AVG FCF Ratio | N/A | 46.13 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -40.96% | 7.07% |
| ROE (TTM) | -51.39% | 12.60% |
| Net Profit Margin (TTM) | -113.83% | 7.96% |
| ROIC 5YR AVG | N/A | 10.94% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 17.55% | 17.66% | N/A |
| Revenue | 27.96% | 70.57% | N/A |
| Net Income | 19.35% | 15.29% | N/A |
| Cash Flow | N/A | -33.91% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.50 | 2.35 |
| Quick Ratio (TTM) | 3.50 | 2.29 |
| D/E Ratio (TTM) | N/A | 0.31 |
| Interest Coverage (TTM) | N/A | 18.50 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 4.79 |
| LTL to 5YR AVG FCF | N/A | 5.83 |
| Shares Outstanding Growth 5YR AVG | N/A | 1.49% |